Ala-Ak-Ct018
ClinicalTrials.gov NCT05060237
Research payments
$745,850
Through program year 2024, $745,850 in research payments was reported against Ala-Ak-Ct018, across 30 payments, paid by Biofrontera Bioscience GmbH.
- Paid by
- Biofrontera Bioscience GmbH
- ClinicalTrials.gov
- NCT05060237
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $22,106 | 5 |
| 2023 | Research | $507,820 | 16 |
| 2022 | Research | $215,924 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Edward Lain Pflugerville, TX Named on 6 payments
- Carl Hanke Indianapolis, IN Named on 5 payments
- Nathalie Zeitouni Phoenix, AZ Named on 3 payments
- Sherrif Ibrahim Victor, NY Named on 3 payments
- Sadra Jazayeri Phoenix, AZ Named on 3 payments
- Joel Cohen Greenwood Village, CO Named on 3 payments
- Megan Couvillion Houston, TX Named on 3 payments
- John Tu Rochester, NY Named on 3 payments
- Todd Schlesinger Charleston, SC Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.